Prostate Cancer - Results from #20620

Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy - Abstract May 6, 2014

Pretreatment tables predicting pathologic stage of locally advanced prostate cancer - Abstract May 6, 2014

Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions - Abstract May 6, 2014

Evaluation of On-Board kV cone beam computed tomography-based dose calculation with deformable image registration using Hounsfield unit modifications - Abstract May 6, 2014

Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions - Abstract May 5, 2014

Partner's perspective on long-term sexual dysfunction after prostate cancer treatment - Abstract May 5, 2014

Focal therapy-a new era in the treatment of prostate cancer - Abstract May 5, 2014

Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society - Abstract May 2, 2014

Biopsy criteria for determining appropriateness for active surveillance in the modern era - Abstract May 2, 2014

Model predictive control for optimally scheduling intermittent androgen suppression of prostate cancer - Abstract May 2, 2014

Baseline serum 25-hydroxyvitamin D levels in men undergoing radical prostatectomy: Is there an association with adverse pathologic features? - Abstract May 2, 2014

Adherence to performance measures and outcomes among men treated for prostate cancer - Abstract May 2, 2014

Unravelling the prostate-specific antigen controversy: A West of Scotland perspective - Abstract May 2, 2014

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: Population based cohort study - Abstract May 2, 2014

Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer - Abstract May 2, 2014

Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer - Abstract May 2, 2014

Myriad Genetics to present three clinical studies on Prolaris® at the 2014 American Urological Association annual meeting May 2, 2014

Metronomic oral cyclophosphamide chemotherapy possibly contributes to stabilization of disease in patients with metastatic castration-resistant prostate cancer: A prospective analysis of consecutive cases - Abstract May 1, 2014

Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison - Abstract May 1, 2014

Prostate and bladder cancer: Detection of disseminated tumor cells in bone marrow - Abstract May 1, 2014

Page 1032 of 1435